Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine

Topological and stereo-electron characteristics are essential in major histocompability class II-peptide-T-cell receptor (MHC-p-TCR) complex formation for inducing an appropriate immune response. Modified high activity binding peptides (mHABPs) were synthesised for complete full protection antimalar...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2014
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23461
Acceso en línea:
https://doi.org/10.1016/j.vaccine.2014.02.003
https://repository.urosario.edu.co/handle/10336/23461
Palabra clave:
protozoan
immunologic
falciparum
Adjuvants
Antibodies
Malaria
Malaria vaccine
Peptide vaccine
Unclassified drug
Very high long lasting antibody inducing modified high activity binding peptide
Animal experiment
Antibody production
Antibody titer
Aotus
Article
Controlled study
Drug mixture
Enzyme linked immunosorbent assay
Gauche side chain orientation
Genotype
Immune response
Immunofluorescence
Immunogenicity
Nonhuman
Priority journal
Protection
Protein structure
Proton nuclear magnetic resonance
Sporozoite
Vaccination
Western blotting
Antimalarial vaccine
Gauche(+)
Peptide mixtures
Protective immunity
?(1) angle
Amino acid sequence
Animals
Antibody formation
Aotus trivirgatus
Binding sites
Hla-dr beta-chains
Malaria vaccines
Molecular sequence data
Oligopeptides
Protein conformation
Antimalarial vaccine
Peptide mixtures
Protective immunity
Rights
License
Abierto (Texto Completo)
id EDOCUR2_537763d2c42ef31419e8718db465edb7
oai_identifier_str oai:repository.urosario.edu.co:10336/23461
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 51890881600aff19004-b704-479b-936e-5ac474fc7141-101a1c86e-e857-46fd-8fa7-3664f825e9ba-12a4e23b6-51d5-4eb5-9889-d4b45c50ee8e-179653065-1a12b8ebf-3c8f-4b8c-b672-f62efd0c2eff-110ecd4f9-843f-4ef2-bec0-7d39d3381a13-12020-05-26T00:02:14Z2020-05-26T00:02:14Z2014Topological and stereo-electron characteristics are essential in major histocompability class II-peptide-T-cell receptor (MHC-p-TCR) complex formation for inducing an appropriate immune response. Modified high activity binding peptides (mHABPs) were synthesised for complete full protection antimalarial vaccine development producing a large panel of individually fully protection-inducing protein structures (FPIPS) and very high long-lasting antibody-inducing (VHLLAI) mHABPs. Most of those which did not interfere, compete, inhibit or suppress their individual VHLLAI or FPIPS activity contained or displayed a polyproline II-like (PPIIL) structure when mixed. Here we show that amino acid side-chains located in peptide binding region (PBR) positions p3 and p7 displayed specific electron charges and side-chain gauche+ orientation for interacting with the TCR. Based on the above, and previously described physicochemical principles, non-interfering, long-lasting, full protection-inducing, multi-epitope, multistage, minimal subunit-based chemically synthesised mHABP mixtures can be designed for developing vaccines against diseases scourging humankind, malaria being one of them. © 2014 Elsevier Ltd.application/pdfhttps://doi.org/10.1016/j.vaccine.2014.02.0030264410X13588745https://repository.urosario.edu.co/handle/10336/23461engElsevier BV2126No. 182117VaccineVol. 32Vaccine, ISSN:0264410X, 13588745, Vol.32, No.18 (2014); pp. 2117-2126https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896548606&doi=10.1016%2fj.vaccine.2014.02.003&partnerID=40&md5=c760298d7f029fff1752b8dc316cca14Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURprotozoanimmunologicfalciparumAdjuvantsAntibodiesMalariaMalaria vaccinePeptide vaccineUnclassified drugVery high long lasting antibody inducing modified high activity binding peptideAnimal experimentAntibody productionAntibody titerAotusArticleControlled studyDrug mixtureEnzyme linked immunosorbent assayGauche side chain orientationGenotypeImmune responseImmunofluorescenceImmunogenicityNonhumanPriority journalProtectionProtein structureProton nuclear magnetic resonanceSporozoiteVaccinationWestern blottingAntimalarial vaccineGauche(+)Peptide mixturesProtective immunity?(1) angleAmino acid sequenceAnimalsAntibody formationAotus trivirgatusBinding sitesHla-dr beta-chainsMalaria vaccinesMolecular sequence dataOligopeptidesProtein conformationAntimalarial vaccinePeptide mixturesProtective immunityGauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccinearticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Bermudez, AdrianaCalderon, DayanaMoreno-Vranich, ArmandoAlmonacid, HanniaPatarroyo, Manuel A.Poloche, AndrésPatarroyo, Manuel E.10336/23461oai:repository.urosario.edu.co:10336/234612022-05-02 07:37:20.98525https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
title Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
spellingShingle Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
protozoan
immunologic
falciparum
Adjuvants
Antibodies
Malaria
Malaria vaccine
Peptide vaccine
Unclassified drug
Very high long lasting antibody inducing modified high activity binding peptide
Animal experiment
Antibody production
Antibody titer
Aotus
Article
Controlled study
Drug mixture
Enzyme linked immunosorbent assay
Gauche side chain orientation
Genotype
Immune response
Immunofluorescence
Immunogenicity
Nonhuman
Priority journal
Protection
Protein structure
Proton nuclear magnetic resonance
Sporozoite
Vaccination
Western blotting
Antimalarial vaccine
Gauche(+)
Peptide mixtures
Protective immunity
?(1) angle
Amino acid sequence
Animals
Antibody formation
Aotus trivirgatus
Binding sites
Hla-dr beta-chains
Malaria vaccines
Molecular sequence data
Oligopeptides
Protein conformation
Antimalarial vaccine
Peptide mixtures
Protective immunity
title_short Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
title_full Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
title_fullStr Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
title_full_unstemmed Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
title_sort Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
dc.subject.keyword.eng.fl_str_mv protozoan
immunologic
falciparum
Adjuvants
Antibodies
Malaria
topic protozoan
immunologic
falciparum
Adjuvants
Antibodies
Malaria
Malaria vaccine
Peptide vaccine
Unclassified drug
Very high long lasting antibody inducing modified high activity binding peptide
Animal experiment
Antibody production
Antibody titer
Aotus
Article
Controlled study
Drug mixture
Enzyme linked immunosorbent assay
Gauche side chain orientation
Genotype
Immune response
Immunofluorescence
Immunogenicity
Nonhuman
Priority journal
Protection
Protein structure
Proton nuclear magnetic resonance
Sporozoite
Vaccination
Western blotting
Antimalarial vaccine
Gauche(+)
Peptide mixtures
Protective immunity
?(1) angle
Amino acid sequence
Animals
Antibody formation
Aotus trivirgatus
Binding sites
Hla-dr beta-chains
Malaria vaccines
Molecular sequence data
Oligopeptides
Protein conformation
Antimalarial vaccine
Peptide mixtures
Protective immunity
dc.subject.keyword.spa.fl_str_mv Malaria vaccine
Peptide vaccine
Unclassified drug
Very high long lasting antibody inducing modified high activity binding peptide
Animal experiment
Antibody production
Antibody titer
Aotus
Article
Controlled study
Drug mixture
Enzyme linked immunosorbent assay
Gauche side chain orientation
Genotype
Immune response
Immunofluorescence
Immunogenicity
Nonhuman
Priority journal
Protection
Protein structure
Proton nuclear magnetic resonance
Sporozoite
Vaccination
Western blotting
Antimalarial vaccine
Gauche(+)
Peptide mixtures
Protective immunity
?(1) angle
Amino acid sequence
Animals
Antibody formation
Aotus trivirgatus
Binding sites
Hla-dr beta-chains
Malaria vaccines
Molecular sequence data
Oligopeptides
Protein conformation
Antimalarial vaccine
Peptide mixtures
Protective immunity
description Topological and stereo-electron characteristics are essential in major histocompability class II-peptide-T-cell receptor (MHC-p-TCR) complex formation for inducing an appropriate immune response. Modified high activity binding peptides (mHABPs) were synthesised for complete full protection antimalarial vaccine development producing a large panel of individually fully protection-inducing protein structures (FPIPS) and very high long-lasting antibody-inducing (VHLLAI) mHABPs. Most of those which did not interfere, compete, inhibit or suppress their individual VHLLAI or FPIPS activity contained or displayed a polyproline II-like (PPIIL) structure when mixed. Here we show that amino acid side-chains located in peptide binding region (PBR) positions p3 and p7 displayed specific electron charges and side-chain gauche+ orientation for interacting with the TCR. Based on the above, and previously described physicochemical principles, non-interfering, long-lasting, full protection-inducing, multi-epitope, multistage, minimal subunit-based chemically synthesised mHABP mixtures can be designed for developing vaccines against diseases scourging humankind, malaria being one of them. © 2014 Elsevier Ltd.
publishDate 2014
dc.date.created.spa.fl_str_mv 2014
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:02:14Z
dc.date.available.none.fl_str_mv 2020-05-26T00:02:14Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.vaccine.2014.02.003
dc.identifier.issn.none.fl_str_mv 0264410X
13588745
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23461
url https://doi.org/10.1016/j.vaccine.2014.02.003
https://repository.urosario.edu.co/handle/10336/23461
identifier_str_mv 0264410X
13588745
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 2126
dc.relation.citationIssue.none.fl_str_mv No. 18
dc.relation.citationStartPage.none.fl_str_mv 2117
dc.relation.citationTitle.none.fl_str_mv Vaccine
dc.relation.citationVolume.none.fl_str_mv Vol. 32
dc.relation.ispartof.spa.fl_str_mv Vaccine, ISSN:0264410X, 13588745, Vol.32, No.18 (2014); pp. 2117-2126
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896548606&doi=10.1016%2fj.vaccine.2014.02.003&partnerID=40&md5=c760298d7f029fff1752b8dc316cca14
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier BV
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167605724839936